Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction
- PMID: 17679795
- DOI: 10.1111/j.1559-4564.2006.06035.x
Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction
Similar articles
-
Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.J Cardiometab Syndr. 2006 Spring;1(2):133-40. doi: 10.1111/j.1559-4564.2006.05487.x. J Cardiometab Syndr. 2006. PMID: 17679832 Review.
-
EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):530-40. doi: 10.1097/HJR.0b013e3283383f30. Eur J Cardiovasc Prev Rehabil. 2010. PMID: 20577089
-
Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study.Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):532-41. doi: 10.1016/j.numecd.2008.11.004. Epub 2009 Mar 25. Nutr Metab Cardiovasc Dis. 2009. PMID: 19321325 Free PMC article.
-
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:S1-113. doi: 10.1097/01.hjr.0000277983.23934.c9. Eur J Cardiovasc Prev Rehabil. 2007. PMID: 17726407 No abstract available.
-
Management of hypertension in children and adolescents with the metabolic syndrome.J Cardiometab Syndr. 2006 Summer;1(4):259-68. doi: 10.1111/j.1559-4564.2006.05801.x. J Cardiometab Syndr. 2006. PMID: 17679805 Review.
Cited by
-
Meta-Analysis of the Effects of Foods and Derived Products Containing Ellagitannins and Anthocyanins on Cardiometabolic Biomarkers: Analysis of Factors Influencing Variability of the Individual Responses.Int J Mol Sci. 2018 Feb 28;19(3):694. doi: 10.3390/ijms19030694. Int J Mol Sci. 2018. PMID: 29495642 Free PMC article. Review.
-
Does the Naked Emperor Parable Apply to Current Perceptions of the Contribution of Renin Angiotensin System Inhibition in Hypertension?Curr Hypertens Rep. 2022 Dec;24(12):709-721. doi: 10.1007/s11906-022-01229-x. Epub 2022 Oct 22. Curr Hypertens Rep. 2022. PMID: 36272015 Review.
-
Impact of performance improvement continuing medical education on cardiometabolic risk factor control: the COSEHC initiative.J Contin Educ Health Prof. 2014 Winter;34(1):25-36. doi: 10.1002/chp.21217. J Contin Educ Health Prof. 2014. PMID: 24648361 Free PMC article.
-
Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan.Integr Blood Press Control. 2014 Nov 26;7:61-70. doi: 10.2147/IBPC.S50954. eCollection 2014. Integr Blood Press Control. 2014. PMID: 25473311 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical